| Previous Close | 4.9 |
| Open | 4.88 |
| Day High | 4.89 |
| Day Low | 4.74 |
| 52-Week High | 13.22 |
| 52-Week Low | 4.48 |
| Volume | 508,712 |
| Average Volume | 912,017 |
| Market Cap | 196.63M |
| PE | -4.2 |
| EPS | -1.13 |
| Moving Average 50 Days | 6.01 |
| Moving Average 200 Days | 7 |
| Change | -0.15 |
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
GlobeNewswire Inc.
Feb 11, 2026 9:10 PM GMT
ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth qu
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
GlobeNewswire Inc.
Jan 11, 2026 2:30 PM GMT
ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preli
RxSight, Inc. Announces Chief Financial Officer Transition
GlobeNewswire Inc.
Dec 22, 2025 10:15 PM GMT
ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Compan